Moniek van Hoppe

Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up

Andrew Davies, Sharon Barrans, Louise Stanton, Josh Caddy et autres

gb, ch (code pays fourni par la source)

Five-Year Survival Results from the Remodl-B Trial (ISRCTN 51837425) Show Improved Outcomes in Diffuse Large B-Cell Lymphoma Molecular Subgroups from the Addition of Bortezomib to R-CHOP Chemoimmunotherapy

Andrew Davies, Louise Stanton, Josh Caddy, Sharon Barrans et autres

gb, ch, cn (code pays fourni par la source)

MOLECULAR HIGH GRADE (MHG) GENE EXPRESSION PROFILE IN DLBCL IS ENRICHED AMONG PATIENTS WITH EARLY TREATMENT FAILURE

Sharon Barrans, Francesco Cucco, John R. Davies, Moniek van Hoppe et autres

gb (code pays fourni par la source)

Molecular High-Grade B-Cell Lymphoma: Defining a Poor-Risk Group That Requires Different Approaches to Therapy

Chulin Sha, Sharon Barrans, Francesco Cucco, Michael A. Bentley et autres

gb, ch (code pays fourni par la source)

Mutation screening using formalin-fixed paraffin-embedded tissues: a stratified approach according to DNA quality

Francesco Cucco, Alexandra Clipson, Hannah Kennedy, Joe Sneath Thompson et autres

gb (code pays fourni par la source)

Identifying somatic mutations in cell‐free DNA of aggressive lymphoma patients: First cell‐free DNA results from the molecular profiling for lymphoma ( MaPLe ) study

Laura D Lopez Pascua, Shabaik Ahmed, Sharon Barrans, Catherine Burton et autres

gb (code pays fourni par la source)

Development of a STR multiplex kit for the individualisation of Hen Harriers (Circus cyaneus)

Moniek van Hoppe

Detection of tumor progression in NSCLC stage IIIB/IV patients by serial measurement of CYFRA 21-1, TPA-M. TPS, and CEA

W. Ébert, Moniek van Hoppe, T. Muley, P. Drings